Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.

Trial Details

NCT ID
NCT07429487
Phase
NA
Sponsor
Centre Antoine Lacassagne
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • APA program
Locations (sample)
  • Nice, France|43.70313,7.26608

Key Eligibility Criteria

  • Patients aged 18 to 75 years old,
  • Histologically proven non-metastatic adenocarcinoma of breast, colorectal, ovarian, pancreatic, biliary, or gastric origin,
  • Adjuvant chemotherapy completed less than 3 months ago (excluding hormone therapy),
  • PS 0 or 1 according to the World Health Organization (WHO) scale,

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →